Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989588 citationsMarco Bregni, A. Stern et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of A. Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Stern more than expected).
This network shows the impact of papers produced by A. Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Stern. The network helps show where A. Stern may publish in the future.
Co-authorship network of co-authors of A. Stern
This figure shows the co-authorship network connecting the top 25 collaborators of A. Stern.
A scholar is included among the top collaborators of A. Stern based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A. Stern. A. Stern is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Shabat, S., A. Stern, Yehuda Kollender, & Meir Nyska. (2001). Continuous intra-articular patient-controlled analgesia in a cancer patient with a pathological hip fracture. A case report.. PubMed. 67(3). 304–6.1 indexed citations
6.
Gerhartz, H, M. Engelhard, G. Brittinger, et al.. (1994). Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.. PubMed. 21(6 Suppl 16). 25–8.5 indexed citations
Stern, A., et al.. (1993). Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.. PubMed. 19(5). 223–7.6 indexed citations
Aglietta, Massimo, Wanda Piacibello, Franco Aprà, et al.. (1990). GM-CSF: intravenous versus subcutaneous treatment.. PubMed. 4(7). 523–523.6 indexed citations
13.
Stern, A., et al.. (1990). Antimicrobial management of postoperative infections in abdominal surgery: single or combination regimen?. PubMed. 12 Suppl B. 34–42.7 indexed citations
14.
Bregni, Marco, A. Stern, Salvatore Siena, et al.. (1989). GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION. The Lancet. 334(8663). 580–585.588 indexed citations breakdown →
15.
Gluckman, E, Gèrard Socié, Antoine Yver, et al.. (1989). Transient cyclic neutropenia following GM-CSF in a patient with chronic granulocytic leukemia transplanted with HLA-identical T cell-depleted donor bone marrow.. PubMed. 4(5). 591–2.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.